Thyritope Biosciences' Series A Round

Thyritope Biosciences raised a round of funding on September 22, 2014.

Thyritope Biosciences is developing therapeutics that target thyroid stimulating auto-antibodies, which are the causative drivers of Graves' hyperthyroidism and Graves' orbitopathy. Graves' disease is…

Articles about Thyritope Biosciences' Series A Round: